Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5903726 | 6775564 | I | 5903726-3 | 20080301 | 20080930 | 20080930 | EXP | JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2008-BP-15054NB | B.I. PHARMACEUTICALS,INC./RIDGEFIELD | M | Y | 35 | KG | 20080930 | 20080717 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5903726 | 1010521559 | PS | MICARDIS | 1 | ORAL | 40MG | 020850 | ||||
| 5903726 | 1010521560 | C | NORVASC | 1 | ORAL | 5MG | |||||
| 5903726 | 1010521561 | C | CALVAN | 2 | ORAL | 2ANZ | |||||
| 5903726 | 1010521562 | C | ANPLAG | 2 | ORAL | 3ANZ |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5903726 | 1010521559 | HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5903726 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 5903726 | CAPLAN'S SYNDROME |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5903726 | 1010521559 | 20060622 | 20080222 | ||
| 5903726 | 1010521560 | 20060802 | 20080222 | ||
| 5903726 | 1010521561 | 20060702 | 20080222 | ||
| 5903726 | 1010521562 | 20060622 | 20080222 |